Author:
Rish Adam J.,Henson Samuel R.,Alam Md. Anik,Liu Yang,Drennen James K.,Anderson Carl A.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Food and Drug Administration. Guidance for industry, PAT-A framework for innovative pharmaceutical development, manufacturing and quality assurance. http://www.fdagov/cder/guidance/published.html. 2004.
2. Badman C, Cooney CL, Florence A, Konstantinov K, Krumme M, Mascia S, et al. Why we need continuous pharmaceutical manufacturing and how to make it happen. J Pharm Sci. 2019;108(11):3521–3. https://doi.org/10.1016/j.xphs.2019.07.016.
3. Roggo Y, Pauli V, Jelsch M, Pellegatti L, Elbaz F, Ensslin S, et al. Continuous manufacturing process monitoring of pharmaceutical solid dosage form: a case study. J Pharm Biomed Anal. 2020;179:112971. https://doi.org/10.1016/j.jpba.2019.112971.
4. Ward HW, Blackwood DO, Polizzi M, Clarke H. Monitoring blend potency in a tablet press feed frame using near infrared spectroscopy. J Pharm Biomed Anal. 2013;80:18–23. https://doi.org/10.1016/j.jpba.2013.02.008.
5. Hetrick EM, Shi Z, Barnes LE, Garrett AW, Rupard RG, Kramer TT, et al. Development of near infrared spectroscopy-based process monitoring methodology for pharmaceutical continuous manufacturing using an offline calibration approach. Anal Chem. 2017;89(17):9175–83. https://doi.org/10.1021/acs.analchem.7b01907.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献